EDAP
ACHAT TOTAL: 20 000 titres (~95 000,00 $ US)
- Insiders
- Horn David R., LEVINE JOSHUA
- Total bought
- $95,000
- Total sold
- —
- Last activity
- 2026-08-14
- Last synced
-
2026-08-21 23:36:53
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-26
Despite a meaningful insider cluster buy signal (score 75, confidence 0.7) following the Q2 2026 earnings call and the FocalTherics/HIFU strategic pivot, the severely distressed financial foundation — persistent net…
The first sentence of the analysis written for EDAP on 2026-08-26 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 42.5% | 41.4% | 40.4% | 43.9% | 41.8% | |
| Ebit Margin | -40.2% | -28.8% | -33.6% | -3.5% | -3.7% | |
| Ebitda Margin | -35.4% | -24.8% | -30.4% | -0.6% | 0.7% | |
| Operating Profit Margin | -35.6% | -32.0% | -32.8% | -7.7% | -3.7% | |
| Pretax Profit Margin | -41.4% | -29.2% | -34.0% | -3.8% | 2.0% | |
| Continuous Operations Profit Margin | -41.5% | -29.7% | -35.0% | -5.3% | 1.6% | |
| Net Profit Margin | -41.5% | -29.7% | -35.0% | -5.3% | 1.6% | |
| Bottom Line Profit Margin | -41.5% | -29.7% | -35.0% | -5.3% | 1.6% | |
| Current Ratio | 1.539 | 1.848 | 2.844 | 4.170 | 3.754 | |
| Quick Ratio | 1.245 | 1.359 | 2.296 | 3.627 | 3.336 | |
| Solvency Ratio | -0.435 | -0.364 | -0.556 | -0.045 | 0.096 | |
| Cash Ratio | 0.469 | 0.789 | 1.575 | 2.908 | 2.628 | |
| Price To Earnings Ratio | -4.218 | -4.185 | -8.380 | -116.710 | 241.633 | |
| Price To Earnings Growth Ratio | -0.080 | 0.398 | -0.015 | 0.238 | -1.760 | |
| Forward Price To Earnings Growth Ratio | -0.080 | 0.398 | -0.015 | 0.238 | -1.760 | |
| Price To Earnings Diluted Ratio | -4.218 | -4.185 | -8.380 | -116.710 | 235.161 | |
| Price To Earnings Diluted Growth Ratio | -0.080 | 0.398 | -0.015 | 0.243 | -1.700 | |
| Price To Book Ratio | 6.345 | 1.946 | 3.105 | 4.780 | 3.381 | |
| Price To Sales Ratio | 1.741 | 1.241 | 2.925 | 6.213 | 3.841 | |
| Price To Free Cash Flow Ratio | -5.557 | -4.500 | -9.314 | -65.756 | 60.466 | |
| Price To Operating Cash Flow Ratio | -7.507 | -5.858 | -12.040 | -113.225 | 38.075 | |
| Debt To Assets Ratio | 0.350 | 0.162 | 0.092 | 0.093 | 0.130 | |
| Debt To Equity Ratio | 1.426 | 0.340 | 0.148 | 0.131 | 0.200 | |
| Debt To Capital Ratio | 0.588 | 0.254 | 0.129 | 0.116 | 0.167 | |
| Long Term Debt To Capital Ratio | 0.450 | 0.050 | 0.034 | 0.048 | 0.090 | |
| Financial Leverage Ratio | 4.069 | 2.104 | 1.608 | 1.412 | 1.543 | |
| Working Capital Turnover Ratio | 2.716 | 1.546 | 1.010 | 0.932 | 1.202 | |
| Operating Cash Flow Ratio | -0.442 | -0.359 | -0.532 | -0.139 | 0.248 | |
| Operating Cash Flow Sales Ratio | -0.232 | -0.212 | -0.243 | -0.055 | 0.101 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.351 | 1.302 | 1.293 | 1.722 | 0.630 | |
| Debt Service Coverage Ratio | -2.823 | -1.825 | -4.477 | -0.320 | 0.041 | |
| Interest Coverage Ratio | -31.852 | -87.008 | -85.401 | -25.339 | -31.000 | |
| Short Term Operating Cash Flow Coverage Ratio | -2.024 | -1.570 | -3.652 | -0.877 | 1.620 | |
| Operating Cash Flow Coverage Ratio | -0.593 | -0.976 | -1.742 | -0.322 | 0.444 | |
| Capital Expenditure Coverage Ratio | -2.849 | -3.312 | -3.417 | -1.385 | 2.700 | |
| Dividend Paid And Capex Coverage Ratio | -2.849 | -3.312 | -3.417 | -1.385 | 2.700 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -5.328 | -3.997 | -7.705 | -903.397 | 427.395 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 42.5% | ▲1.1% | ▲0.5% |
| Ebit Margin | -40.2% | ▼-11.4% | ▼-18.3% |
| Ebitda Margin | -35.4% | ▼-10.6% | ▼-17.3% |
| Operating Profit Margin | -35.6% | ▼-3.6% | ▼-13.3% |
| Pretax Profit Margin | -41.4% | ▼-12.2% | ▼-20.1% |
| Continuous Operations Profit Margin | -41.5% | ▼-11.8% | ▼-19.5% |
| Net Profit Margin | -41.5% | ▼-11.8% | ▼-19.5% |
| Bottom Line Profit Margin | -41.5% | ▼-11.8% | ▼-19.5% |
| Current Ratio | 1.539 | ▼-0.309 | ▼-1.292 |
| Quick Ratio | 1.245 | ▼-0.114 | ▼-1.127 |
| Solvency Ratio | -0.435 | ▼-0.071 | ▼-0.174 |
| Cash Ratio | 0.469 | ▼-0.320 | ▼-1.205 |
| Price To Earnings Ratio | -4.218 | ▼-0.033 | ▼-25.846 |
| Price To Earnings Growth Ratio | -0.080 | ▼-0.477 | ▲0.164 |
| Forward Price To Earnings Growth Ratio | -0.080 | ▼-0.477 | ▲0.164 |
| Price To Earnings Diluted Ratio | -4.218 | ▼-0.033 | ▼-24.552 |
| Price To Earnings Diluted Growth Ratio | -0.080 | ▼-0.477 | ▲0.151 |
| Price To Book Ratio | 6.346 | ▲4.400 | ▲2.434 |
| Price To Sales Ratio | 1.741 | ▲0.500 | ▼-1.451 |
| Price To Free Cash Flow Ratio | -5.557 | ▼-1.057 | ▼-0.625 |
| Price To Operating Cash Flow Ratio | -7.507 | ▼-1.649 | ▲12.604 |
| Debt To Assets Ratio | 0.350 | ▲0.189 | ▲0.185 |
| Debt To Equity Ratio | 1.426 | ▲1.086 | ▲0.977 |
| Debt To Capital Ratio | 0.588 | ▲0.334 | ▲0.337 |
| Long Term Debt To Capital Ratio | 0.450 | ▲0.400 | ▲0.316 |
| Financial Leverage Ratio | 4.069 | ▲1.965 | ▲1.922 |
| Working Capital Turnover Ratio | 2.716 | ▲1.171 | ▲1.235 |
| Operating Cash Flow Ratio | -0.442 | ▼-0.083 | ▼-0.197 |
| Operating Cash Flow Sales Ratio | -0.232 | ▼-0.020 | ▼-0.104 |
| Free Cash Flow Operating Cash Flow Ratio | 1.351 | ▲0.049 | ▲0.091 |
| Debt Service Coverage Ratio | -2.823 | ▼-0.999 | ▼-0.943 |
| Interest Coverage Ratio | -31.852 | ▲55.157 | ▲20.268 |
| Short Term Operating Cash Flow Coverage Ratio | -2.024 | ▼-0.454 | ▼-0.724 |
| Operating Cash Flow Coverage Ratio | -0.593 | ▲0.383 | ▲0.045 |
| Capital Expenditure Coverage Ratio | -2.849 | ▲0.463 | ▼-1.197 |
| Dividend Paid And Capex Coverage Ratio | -2.849 | ▲0.463 | ▼-1.197 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -5.328 | ▼-1.332 | ▲93.278 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $123.2M | $79.6M | $176.7M | $342.4M | $169.2M | |
| Enterprise value | $133.5M | $63.7M | $141.7M | $288.6M | $132.1M | |
| EV / Sales | 1.89x | 0.99x | 2.35x | 5.24x | 3.00x | |
| EV / Op. cash flow | -8.13x | -4.69x | -9.65x | -95.45x | 29.71x | |
| EV / Free cash flow | -6.02x | -3.60x | -7.47x | -55.43x | 47.18x | |
| EV / EBITDA | -5.33x | -4.00x | -7.71x | -903.40x | 427.39x | |
| Net debt / EBITDA | -0.41x | 1.00x | 1.91x | 168.24x | -120.32x | |
| Current ratio | 1.54x | 1.85x | 2.84x | 4.17x | 3.75x | |
| Income quality | 0.56x | 0.71x | 0.69x | 1.03x | 6.35x | |
| Graham number | — | — | — | — | $1 | |
| Graham net-net | -$1 | $0 | $1 | $1 | $1 | |
| Tax burden | 100.2% | 101.5% | 103.1% | 139.9% | 78.4% | |
| Interest burden | 102.8% | 101.3% | 101.1% | 108.7% | -55.4% | |
| Working capital | $20.0M | $32.1M | $50.9M | $68.8M | $49.4M | |
| Invested capital | $36.1M | $45.9M | $62.6M | $77.9M | $57.7M | |
| Return on assets | -37.1% | -22.1% | -23.1% | -2.9% | 0.9% | |
| Operating ROA | -30.5% | -23.1% | -20.6% | -4.8% | -2.4% | |
| Return on tangible assets | -39.4% | -23.0% | -24.1% | -3.0% | 0.9% | |
| Return on equity | -151.1% | -46.5% | -37.2% | -4.1% | 1.4% | |
| Return on invested capital | -49.2% | -35.4% | -28.7% | -5.1% | -2.0% | |
| Return on capital employed | -60.2% | -42.6% | -31.0% | -5.4% | -2.7% | |
| Earnings yield | -23.8% | -23.9% | -12.0% | -0.9% | 0.4% | |
| Free cash flow yield | -18.0% | -22.2% | -10.7% | -1.5% | 1.7% | |
| Capex / Op. cash flow | -35.1% | -30.2% | -29.3% | -72.2% | 37.0% | |
| Capex / Depreciation | 169.0% | 159.9% | 224.6% | 136.0% | 85.7% | |
| Capex / Sales | 8.1% | 6.4% | 7.1% | 4.0% | 3.7% | |
| SG&A / Sales | 63.7% | 61.4% | 61.7% | 42.7% | 37.7% | |
| R&D / Sales | 12.1% | 12.1% | 11.5% | 8.9% | 10.8% | |
| Stock comp / Sales | 3.6% | 5.1% | 11.4% | 3.8% | 4.3% | |
| Intangibles / Total assets | 5.9% | 4.1% | 3.8% | 3.1% | 4.1% | |
| Days sales outstanding | 117d | 116d | 102d | 99d | 100d | |
| Days payables outstanding | 158d | 122d | 114d | 78d | 78d | |
| Operating cycle | 215d | 295d | 256d | 238d | 207d | |
| Cash conversion cycle | 56d | 173d | 142d | 160d | 129d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-13 EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript
- 2026-08-04 McDonald''s Corp (MCD) (Q2 2026) Earnings Call Highlights: Navigating US Execution Challenges While Driving Global Growth System-wide Sales Growth: 4% increase in constant currency for the second quarter; 5% increase for the first half of the year.Global Comparable Sales: 1.3% grow
- 2026-06-01 Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion Edap Tms NASDAQ: EDAP used its 2026 FocalTherics Investor Day to outline its shift toward becoming a “high-growth, pure-play robotic focal therapy company,” with management emphasizing the company''s Focal One robotic high-intensity focused ultrasound, or HIFU, platform for prostate cancer and future indications.
- 2026-05-29 EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy , May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics ™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
- 2026-05-29 EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy , May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy Company will Begin Trading Under New Ticker Symbol "FOCL" at Market Open on June 1, 2026Company Intends to Report and Classify its Legacy Non-Core ESWL and Distribution Operating Segments as Discontinued Operations Beginning with Second Quarter 2026 Financial ResultsInvestor Day to be Held on June 1, 2026 to Highlight Company Vision and Long-Term Strategy under New FocalTherics Corporate Identity AUSTIN, Texas, May 29, 2026 - EDAP TMS S.
- 2026-05-21 EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference , May 21, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference